Company / Current Liabilities
Centessa Pharmaceuticals plc Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$42.9M
FY2025
5-year range
$24.6M / $58.0M
FY2021-FY2025
Trend
-26.0%
vs FY2024
Sector context
#154 of 213
Health Care
What the data says
At $43M, Centessa Pharmaceuticals plc's current liabilities ranks #60 of 213 in the Health Care sector. Increased from $39M to $43M over the past 2 years.
Based on SEC 10-K filings.
$43M in FY2025 with a 5-year CAGR of +37.9%.
Increased from $39M to $43M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +3.8%
- 5-Year CAGR
- +37.9%
- 10-Year CAGR
- -
Sector benchmark
#60 of 213 in Health CareTop 28% of 213This company $42.9M Sector average $1.6B
▼
-97.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +37.9%, indicating consistent growth.
- In FY2025, current liabilities decreased 26.0% year-over-year.
- Ranks #154 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.9M | -26.0% |
| FY2024 | $58.0M | +47.3% |
| FY2023 | $39.4M | +2.7% |
| FY2022 | $38.3M | +55.6% |
| FY2021 | $24.6M | +185.9% |
| FY2020 | $8.6M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026